
【新年特輯】解析肺腺癌的基因檢測與治療選擇:ROS1基因突變的臨床應用 Real-World Case Study from Diagnosis to Treatment【完整版】
2026年2月9日
❤️Youtube Member 成為這個頻道的會員並獲得福利:
https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join
❤️Facebook 臉書粉專: https://m.facebook.com/profile.php/?id=100063644122566
❤️IG: https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA==
在肺腺癌的治療中,基因檢測是關鍵,特別是針對EGFR、ALK和ROS1基因突變。今天的影片將深入探討ROS1基因突變的診斷挑戰與治療選擇,包括NGS基因定序與FISH檢測的比較,並分享真實病例的治療經驗。透過這些知識,幫助患者了解ROS1突變的治療潛力與未來發展趨勢。
Genetic testing in lung cancer opens doors to precision medicine. Today, we share a rare case of a squamous cell carcinoma patient with a ROS1 mutation who achieved remarkable improvement through targeted therapy. This video explores the importance of genetic testing, clinical decision-making, and the future of gene-driven treatments.
